Poolbeg Pharma PLC Announces Annual Report & AGM Notice
Accesswire
*LONDON, UK / ACCESSWIRE / May 9, 2024 / *Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a..
*LONDON, UK / ACCESSWIRE / May 9, 2024 / *Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a..
*Notice of Allowance for Significant POLB 001 Patent in United States*
Notice of Allowance for Immunomodulator II further..
*Further Data Confirms POLB 001's Potential in Cancer Immunotherapy-Induced Cytokine Release Syndrome (CRS)*
*Market..